Welcome to Ligand Pharmaceuticals

Ligand is a high-growth company with economic rights to some of the world's most important medicines.

Portfolio
Technologies
Licensing Opportunities

Investor Relations

View Investor Relations

Latest News

Ligand Provides Highlights from Today’s Analyst Day Event

Read More

Ligand Reports Third Quarter 2017 Financial Results

Read More

Reminder: Ligand to Host Analyst Day on November 14th in New York City

Read More

Recent Events

Stock Snapshot

LGND
NASDAQ
Volume
Market Cap
Day Range
52-Week Range